2000kms apart - Working together. How a team of Australian Neuroendocrine Cancer Nurses are delivering a National Supportive Care Service for People Living with Neuroendocrine Cancer
2000kms apart - Working together. How a team of Australian Neuroendocrine Cancer Nurses are delivering a National Supportive Care Service for People Living with Neuroendocrine Cancer
Twelve national organisations call for urgent Medicare reforms to address delays in diagnosis, fragmented care and avoidable hospital admissions in regional, rural and remote parts of Australia.
Exercise is widely recognised as a vital component of cancer care, supporting treatment tolerance, physical function, and overall quality of life. In this webinar, we explored how to confidently respond to common patient questions such as “Is it safe for me to exercise?”, “What should I avoid?”, and “Can I still exercise with metastatic disease?”
In this episode of Nursing Excellence in Cancer Care, CEO Jemma Still and President Anne Mellon unpack why 2026 is a pivotal year for cancer nursing. They discuss the redevelopment of the Australian Cancer Nursing Framework, workforce pressures and burnout, national moves toward post‑graduate accreditation, and CNSA’s new cancer nursing education portal.
Following the 1 March 2026 Pharmaceutical Benefits System (PBS) updated listings for ipilimumab and nivolumab for the treatment of immunotherapy sensitive, advanced or metastatic cancers, eviQ has published its first broad indication tumour-agnostic immunotherapy protocol.
